Evra Transdermal Patch is a prescription medication containing norelgestromin and ethinylestradiol hormones. Each patch delivers 203 micrograms of norelgestromin and 34 micrograms of ethinylestradiol over 24 hours through the skin. The package contains 3 patches manufactured by Janssen Pharmaceuticals. This is a prescription-only medication that requires proper medical consultation before use. The patches are designed for transdermal administration, meaning the hormones are absorbed through the skin over a 24-hour period. Each patch should be applied according to specific medical guidance and prescription instructions. The patches provide continuous hormone delivery through a controlled-release system.